Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Excellent work Cliff!

From the 10-K:

"In July 2011 we received $38,985 from Deutsche Bank relating to partial redemptions of auction rate securities occurring on June 1, 2011. Such amount is a recovery on the $600,879 realized loss on sale of marketable securities recognized during the fiscal year ended May 31, 2011. Deutsche Bank had repurchased our illiquid auction rate securities pursuant to our settlement agreement with them in September 2010."

Anybody else "tingly" like me?

Share
New Message
Please login to post a reply